HUMAN DISEASE MODELED by aldh7a1^{zf2074/zf2074}

Human Disease	Conditions	Citations
pyridoxine-dependent epilepsy	standard conditions	Zabinyakov et al., 2017
epilepsy	standard conditions	Zabinyakov et al., 2017

GENE EXPRESSION
Gene expression in aldh7a1^{zf2074/zf2074}

PHENOTYPE
Phenotype in aldh7a1^{zf2074/zf2074}

Phenotype	Conditions	Figures
regulation of neuronal action potential disrupted, abnormal	chemical treatment: phenobarbital	Fig. 4 ,  Fig. 5  from Zabinyakov et al., 2017
regulation of neuronal action potential disrupted, abnormal	control	Fig. 4 ,  Fig. 5  from Zabinyakov et al., 2017
regulation of neuronal action potential disrupted, abnormal	chemical treatment: diazepam	Fig. 4 ,  Fig. 5  from Zabinyakov et al., 2017
regulation of neuronal action potential disrupted, ameliorated	chemical treatment: pyridoxine	Fig. 4  from Zabinyakov et al., 2017
regulation of neuronal action potential disrupted, ameliorated	chemical treatment: phenobarbital, chemical treatment: pyridoxine	Fig. 5  from Zabinyakov et al., 2017
regulation of neuronal action potential disrupted, ameliorated	chemical treatment: diazepam, chemical treatment: pyridoxine	Fig. 5  from Zabinyakov et al., 2017
swimming decreased duration, abnormal	standard conditions	Fig. 3  from Zabinyakov et al., 2017
swimming decreased occurrence, abnormal	standard conditions	Fig. 3  from Zabinyakov et al., 2017
whole organism dead, abnormal	standard conditions	Fig. 2  from Zabinyakov et al., 2017
whole organism 1-piperideine-6-carboxylate increased amount, abnormal	standard conditions	Fig. 6  from Zabinyakov et al., 2017
whole organism allysine increased amount, abnormal	standard conditions	Fig. 6  from Zabinyakov et al., 2017
whole organism pipecolic acid increased amount, abnormal	standard conditions	Fig. 6  from Zabinyakov et al., 2017